Blood pressure drug recalled in Spain

Blood pressure drug recalled in Spain. The Spanish Agency for Medicines and Health Products (Aemps) have recalled a popular blood pressure drug in Spain due to the presence of impurities.

The Spanish Agency for Medicines and Health Products (Aemps) reports to Spain’s Ministry of Health and they have ordered that a batch of Karvezide 300mg is recalled. The drug is a blood pressure medicine and it has been found to contain impurities that are said to be above the acceptable limits. The impurities have been found in the active ingredient which is called irbersartan.

It was only last week that another recall was issued for several batches of batches of Irbesartan Normon and Coaprovel, two drugs also used to treat high blood pressure.

As reported El Espanol, “Specifically, the Agency warns that batch FT015 of Karvezide 300mg/12.5mg, with an expiry date of 28 February 2023, is affected. The medicine comes in film-coated tablet packs of 28 tablets.”

Two batches of Coaprovel 300mg and around 20 batches of the anti-high blood pressure medicines Irbesartan and Valsartan have also been recalled by Aemps. It has been discovered that they have the same defect.

Anyone worried about the medications that they are taking should head to see their doctor or their nearest pharmacist.

In other Spanish news, Baby orangutan delights crowds at Spanish zoo in Spain’s Fuengirola.  The baby orangutan was born earlier this month at Bioparc Fuengirola and is making itself feel at home, much to the delight of crowds.

The Fuengirola Biopark centre is home to a conservation programme for Bornean orangutans. Sadly, the species has been deemed critically endangered by the International Union for Conservation of Nature (IUCN).

The baby orangutan was born on August 4 and is the only Bornean orangutan to be born in Europe over the last 12 months. The baby was born as part of the European program for conservation of the species.

Thank you for reading, and don’t forget to check The Euro Weekly News for all your up-to-date local and international news stories.